Drawing for ICHALIG

USPTO serial 79257626

ICHALIG

Reviewed by CopyMark Law Group

Reg. 6021067Status 700Registered
Filing date
Status date
Registration date
Mar 31, 2020
Examiner
SAKAI, ADA HAN
Law office
TMEG LAW OFFICE 106

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ICHALIG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Zhi Dong

Zhi Dong Hamre, Schumann, Mueller & Larson, P.C.45 South Seventh Street, Suite 2700Minneapolis, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; medicines for use in human for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 29, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 31, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 25, 2021COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Feb 24, 2021EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Dec 23, 2020PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
Dec 8, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 3, 2020ES7RTEAS SECTION 7 REQUEST RECEIVED—
Aug 29, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 6, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 6, 2020FIMPFINAL DISPOSITION PROCESSED—
Jun 30, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 31, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 10, 2020GPNXNOTIFICATION PROCESSED BY IB—
Dec 25, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 25, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 25, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 11, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 6, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 6, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 5, 2019ALIEASSIGNED TO LIE—
Nov 26, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 14, 2019RFNTREFUSAL PROCESSED BY IB—
May 30, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 30, 2019RFRRREFUSAL PROCESSED BY MPU—
May 7, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
May 4, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 3, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2019DOCKASSIGNED TO EXAMINER—
May 3, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 2, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance